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Abstract 
Background: A growing use of complementary alternative medicine (CAM) has been found in Europe as well in Italy 
for chronic diseases, including the allergic rhinitis. The study aims at investigating the prevalence and the pattern of 
use of CAM amongst patient with allergic rhinitis.
Methods: A 12-item questionnaire was developed by a panel of experts and administered to patients with mod-
erate/severe allergic rhinitis consecutively referring during the study time-frame to seven allergy clinics placed all 
around Italy. The items covered several topics including reason for choosing CAM, its clinical efficacy, schedule of 
treatment, costs, type of therapy.
Results: Overall 359 questionnaires were analysed. 20% of patients declared CAM use. A significant correlation 
between the use of CAM and female sex (p < 0.01) and with a higher level of education (p < 0.01) was observed. 
CAM users were adults (36% in the range between 20 and 40 years and 32% between 41 and 60 years). Youngsters 
(< 20 years) (7%) and elderly (> 60) (25%) less frequently used CAM.The most used type of CAM was homoeopathy 
(77% of patients). 60% of users would recommend CAM despite a poor clinical efficacy according to 67% of them.
Conclusions: Although no evidence supports CAM efficacy and safety, the number of patients who relies on it is not 
negligible. As allergic rhinitis is not a trivial disease, the use of CAM as the only treatment for it should be discouraged 
at any level, but by general practitioner and specialist in particular.
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Background
A growing use of complementary alternative medicine 
(CAM) has been found in Europe as well in Italy for 
chronic diseases, including the allergic rhinitis [1–3]. 
Allergic rhinitis is a very common disease; its preva-
lence in Italy is more than 20% [4]. According to a sur-
vey only 48% of patients suffering from rhinitis have seen 
a medical doctor in the last year and 26% of them used 
homeopathic therapy or are completely untreated: the 
cost of allergy medication is the reason for avoiding any 
treatment in 40% of cases [5]. In a recent Italian survey 
most of investigated patients (68%) received the pre-
scription of the first therapy in the GP setting, whereas 
self diagnosis and self treatment were the first choice 
in the remaining subjects, who looked for advices from 
pharmacists, internet, magazines, friends and relatives 
[6]. More than 50% of patients with allergic rhinitis used 
multiple therapies for their disease, but 40% of them were 
not satisfied (6). CAM is wildly used as an alternative or 
in conjunction with traditional treatment. In the present 
study we aimed at investigating the prevalence and the 
pattern of use of CAM among patient with allergic rhini-
tis referring to an allergy clinic.
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Methods
A 12-item questionnaire was developed by a panel of 
experts and administered to patients with moderate to 
severe allergic rhinitis, according to ARIA classification 
[7], consecutively referring to seven allergy clinics placed 
all around Italy, during the study time-frame (30th May 
to 31 October 2016). It was intended to be a question-
naire for self-compilation. The items covered several 
topics the following topics: reason for choosing CAM, 
its clinical efficacy, schedule of treatment, costs, type of 
therapy. Demographic data associated with information 
concerning school education were also collected. Statis-
tical analysis was performed for comparing CAM users 
with those who had no experience of such methods. Chi 
squared test was used for the analysis.
Results
Overall 359 consenting adult respondents were enrolled. 
The reported prevalence of CAM use was 20% (70 
patients). The main findings of the survey are summa-
rized in Tables 1 and 2. A significant correlation between 
the use of CAM and female sex (p < 0.01) and with a 
higher level of education (p < 0.01) was observed. CAM 
users were adults (36% in the range between 20 and 
40 years and 32% between 41 and 60 years). Youngsters 
(< 20 years) (7%) and elderly (> 60) (25%) less frequently 
used CAM. The most common type of CAM was homoe-
opathy (77% of patients). Among the CAM users, 67% 
reported a substantial lack of clinical efficacy, but 61% of 
them would recommend the treatment. The most com-
mon reason for choosing it was that it is a natural treat-
ment; a further reason was the fear of side effects related 
to traditional medicine.
Mass media (40%) and family or friends (48%) were the 
major source of information about CAM. Of notice 37% 
of CAM users declared they received information form 
their General Practitioners (GPs).
Discussion
This survey showed a fairly large use of CAM among 
patients with allergic rhinitis, mainly adults, though 
with poor benefits, as reported by 67% of respondents. 
Homoeopathy was the main form of CAM used, followed 
by herbal remedies. Despite the ARIA guideline do not 
suggest the use of CAM [8], GPs prescribed or recom-
mended CAM to their patients in 37% of cases. Other 
important providers of information were newspapers 
and the web. This finding might account for the preva-
lence of CAM users among young adults, who are more 
Table 1 Demographic data of sample population
Patients Total N. CAM users (%) N. CAM non 
users (%)
p value
Sex
 Males 152 18 (25) 134 (25)
 Females 207 53 (75) 53 (75) < 0.01
Education
 Elementary 43 3 (4) 40 (14) < 0.05
 Middle school 82 13 (19) 69 (24)
 High school 168 30 (42) 138 (48)
 University 66 25 (35) 41 (14) < 0.01
Age
 < 20 25 4 (7) 21 (7) > 0.05
 20–40 128 30 (36) 98 (34)
 41–60 116 26 (32) 90 (31)
 > 60 90 11 (25) 79 (28)
Table 2 Pattern of use in CAM users
a More than one choice for each patient
Number pts (%)
Type of  therapya
 Homoeopathy 55 (77)
 Herbal remedies 28 (39)
 Acupuncture 8 (11)
 Other 8 (11)
Treatment duration
 < 6 months 20 (28)
 > 6 months 52 (72)
Schedule of treatment
 Regular 43 (60)
 On demand 28 (40)
Clinical efficacy
 Yes 24 (33)
 No 47 (67)
Cost/month
 < 50 Euro 32 (45)
 > 50 euro 39 (55)
Reason for  choicea
 Natural 40 (56)
 Fear of side effects of traditional Medicine 39 (55)
 Dissatisfaction with traditional medicine 13 (18)
 Other 21 (30)
Providers of  informationa
 GP 26 (37)
 TV or newspaper, websites 31 (40)
 Family and friends 34 (48)
 Other 6 (8)
Recommendation for CAM use
 Yes 43 (61)
 No 28 (39)
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familiar with these means of communication. CAM costs 
are comparable or even higher than traditional therapies; 
patients with high education level are more frequently 
“CAM consumers”, perhaps because they can better 
afford its costs. Though CAM is pricey and patients pay 
out of pocket its costs, patients prefer to follow the treat-
ment on regular basis. However, no data about the adher-
ence to these treatments are available.
The more frequent reason for the choice was the fear 
of potential side effects related to traditional medi-
cine. However, despite the common belief that CAM is 
completely safe, there is a risk of toxicity, malignancies, 
mechanical injuries and drug interaction [9]. Recently 
also severe allergic reaction has been reported [10].
The survey results highlight two major pitfalls in the 
management of allergic rhinitis. First, patients do not 
refer to their GP or to the specialist when they suffer 
from nasal symptoms. Second, strictly connected with 
the first one, there is a substantial lack of knowledge 
about the treatment options for nasal symptoms, their 
potential benefits and their side effects. One potential 
explanation is that the nasal symptoms are considered 
somehow trivial, so they not deserve a serious assessment 
according to the patients, as previously described [6, 
11]. As allergic rhinitis is not a trivial disease, the use of 
CAM as the only treatment for it should be discouraged 
at any level, but by general practitioner and specialist in 
particular. Also, as pharmacies are often the first line of 
referral for the patients suffering from allergic rhinitis [6, 
11], they should be more extensively involved in shared 
educational programmes so that they support doctor in 
providing correct information about nasal symptoms 
treatment options and promoting medical referral for the 
best assessment.
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